MACROH2A1 and neoplasm: Using two CRC cell lines, they also showed that siRNA-mediated macroH2A1 silencing led to decreased tumor proliferation after rescue of p16 expression, suggesting that macroH2A1 could be considered an oncoprotein [78] (Figure 2).